Παρασκευή 10 Φεβρουαρίου 2017

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Objective To examine clinical effectiveness and safety of apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg compared with warfarin among patients with atrial fibrillation who had not...
recent?d=yIl2AUoC8zA recent?d=dnMXMwOfBR0 recent?i=zmlyKk5gMcI:ldwMyghWWlc:V_sGLiP recent?d=qj6IDK7rITs recent?i=zmlyKk5gMcI:ldwMyghWWlc:gIN9vFw recent?d=l6gmwiTKsz0 recent?d=7Q72WNTAKBA recent?i=zmlyKk5gMcI:ldwMyghWWlc:F7zBnMy recent?i=zmlyKk5gMcI:ldwMyghWWlc:-BTjWOF


from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lvK6g6
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις